Exact Mass: 431.18384540000005
Exact Mass Matches: 431.18384540000005
Found 500 metabolites which its exact mass value is equals to given mass value 431.18384540000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Glenvastatin
C27H26FNO3 (431.18966180000007)
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites
DTXSID10996162
C23H36Cl3N (431.19131860000005)
Fusarin C
Fusarin C is produced by many Fusarium species in infected corn. Production by many Fusarium subspecies in infected corn. D009676 - Noxae > D009153 - Mutagens
Lafutidine
C22H29N3O4S (431.1878674000001)
Lafutidine is a histamine H2-receptor antagonist that inhibits histamine-stimulated gastric acid secretion. Due to the resulting reduction in gastric volume and acidity, lafutidine can be used to treat ulcers and reflux. A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].
(3S,11R,11aR)-3-Methoxy-4,9-dimethyl-8beta-hydroxy-3beta-[[(2S,4S)-4-methyl-5-oxotetrahydrofuran]-2-yl]-2,3,5,6,7,8-hexahydrospiro[1H-cyclopenta[b]pyrrolo[1,2-a]azepine-11(10H),2(5H)-furan]-5,10-dione
4-methoxy-3-methyl-5-[(2Z,3aR)-3ac,10c-epoxy-1t-methyl-8t-((2S)-4c-methyl-5-oxo-tetrahydrofuran-2r-yl)-(3ar,10at,10bt)-decahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepin-2-ylidene]-5H-furan-2-one|oxyprotostemonine
Lafutidine
C22H29N3O4S (431.1878674000001)
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].
Ala Asp Ile Asn
Ala Asp Leu Asn
Ala Asp Asn Ile
Ala Asp Asn Leu
Ala Asp Gln Val
Ala Asp Val Gln
Ala Glu Asn Val
Ala Glu Val Asn
Ala Ile Asp Asn
Ala Ile Asn Asp
Ala Leu Asp Asn
Ala Leu Asn Asp
Ala Met Asn Pro
C17H29N5O6S (431.18384540000005)
Ala Met Pro Asn
C17H29N5O6S (431.18384540000005)
Ala Asn Asp Ile
Ala Asn Asp Leu
Ala Asn Glu Val
Ala Asn Ile Asp
Ala Asn Leu Asp
Ala Asn Met Pro
C17H29N5O6S (431.18384540000005)
Ala Asn Asn Asn
Ala Asn Pro Met
C17H29N5O6S (431.18384540000005)
Ala Asn Val Glu
Ala Pro Met Asn
C17H29N5O6S (431.18384540000005)
Ala Pro Asn Met
C17H29N5O6S (431.18384540000005)
Ala Gln Asp Val
Ala Gln Val Asp
Ala Val Asp Gln
Ala Val Glu Asn
Ala Val Asn Glu
Ala Val Gln Asp
Cys Gly Pro Arg
C16H29N7O5S (431.19507840000006)
Cys Gly Arg Pro
C16H29N7O5S (431.19507840000006)
Cys Asn Pro Val
C17H29N5O6S (431.18384540000005)
Cys Asn Val Pro
C17H29N5O6S (431.18384540000005)
Cys Pro Gly Arg
C16H29N7O5S (431.19507840000006)
Cys Pro Asn Val
C17H29N5O6S (431.18384540000005)
Cys Pro Arg Gly
C16H29N7O5S (431.19507840000006)
Cys Pro Val Asn
C17H29N5O6S (431.18384540000005)
Cys Arg Gly Pro
C16H29N7O5S (431.19507840000006)
Cys Arg Pro Gly
C16H29N7O5S (431.19507840000006)
Cys Val Asn Pro
C17H29N5O6S (431.18384540000005)
Cys Val Pro Asn
C17H29N5O6S (431.18384540000005)
Asp Ala Ile Asn
Asp Ala Leu Asn
Asp Ala Asn Ile
Asp Ala Asn Leu
Asp Ala Gln Val
Asp Ala Val Gln
Asp Gly Ile Gln
Asp Gly Leu Gln
Asp Gly Gln Ile
Asp Gly Gln Leu
Asp Ile Ala Asn
Asp Ile Gly Gln
Asp Ile Asn Ala
Asp Ile Gln Gly
Asp Leu Ala Asn
Asp Leu Gly Gln
Asp Leu Asn Ala
Asp Leu Gln Gly
Asp Asn Ala Ile
Asp Asn Ala Leu
Asp Asn Ile Ala
Asp Asn Leu Ala
Asp Asn Pro Ser
Asp Asn Ser Pro
Asp Pro Asn Ser
Asp Pro Ser Asn
Asp Gln Ala Val
Asp Gln Gly Ile
Asp Gln Gly Leu
Asp Gln Ile Gly
Asp Gln Leu Gly
Asp Gln Val Ala
Asp Ser Asn Pro
Asp Ser Pro Asn
Asp Val Ala Gln
Asp Val Gln Ala
Glu Ala Asn Val
Glu Ala Val Asn
Glu Gly Ile Asn
Glu Gly Leu Asn
Glu Gly Asn Ile
Glu Gly Asn Leu
Glu Gly Gln Val
Glu Gly Val Gln
Glu Ile Gly Asn
Glu Ile Asn Gly
Glu Leu Gly Asn
Glu Leu Asn Gly
Glu Asn Ala Val
Glu Asn Gly Ile
Glu Asn Gly Leu
Glu Asn Ile Gly
Glu Asn Leu Gly
Glu Asn Val Ala
Glu Gln Gly Val
Glu Gln Val Gly
Glu Val Ala Asn
Glu Val Gly Gln
Glu Val Asn Ala
Glu Val Gln Gly
Gly Cys Pro Arg
C16H29N7O5S (431.19507840000006)
Gly Cys Arg Pro
C16H29N7O5S (431.19507840000006)
Gly Asp Ile Gln
Gly Asp Leu Gln
Gly Asp Gln Ile
Gly Asp Gln Leu
Gly Glu Ile Asn
Gly Glu Leu Asn
Gly Glu Asn Ile
Gly Glu Asn Leu
Gly Glu Gln Val
Gly Glu Val Gln
Gly Ile Asp Gln
Gly Ile Glu Asn
Gly Ile Asn Glu
Gly Ile Gln Asp
Gly Leu Asp Gln
Gly Leu Glu Asn
Gly Leu Asn Glu
Gly Leu Gln Asp
Gly Met Pro Gln
C17H29N5O6S (431.18384540000005)
Gly Met Gln Pro
C17H29N5O6S (431.18384540000005)
Gly Asn Glu Ile
Gly Asn Glu Leu
Gly Asn Ile Glu
Gly Asn Leu Glu
Gly Asn Asn Gln
Gly Asn Gln Asn
Gly Pro Cys Arg
C16H29N7O5S (431.19507840000006)
Gly Pro Met Gln
C17H29N5O6S (431.18384540000005)
Gly Pro Gln Met
C17H29N5O6S (431.18384540000005)
Gly Pro Arg Cys
C16H29N7O5S (431.19507840000006)
Gly Gln Asp Ile
Gly Gln Asp Leu
Gly Gln Glu Val
Gly Gln Ile Asp
Gly Gln Leu Asp
Gly Gln Met Pro
C17H29N5O6S (431.18384540000005)
Gly Gln Asn Asn
Gly Gln Pro Met
C17H29N5O6S (431.18384540000005)
Gly Gln Val Glu
Gly Arg Cys Pro
C16H29N7O5S (431.19507840000006)
Gly Arg Pro Cys
C16H29N7O5S (431.19507840000006)
Gly Val Glu Gln
Gly Val Gln Glu
Ile Ala Asp Asn
Ile Ala Asn Asp
Ile Asp Ala Asn
Ile Asp Gly Gln
Ile Asp Asn Ala
Ile Asp Gln Gly
Ile Glu Gly Asn
Ile Glu Asn Gly
Ile Gly Asp Gln
Ile Gly Glu Asn
Ile Gly Asn Glu
Ile Gly Gln Asp
Ile Asn Ala Asp
Ile Asn Asp Ala
Ile Asn Glu Gly
Ile Asn Gly Glu
Ile Gln Asp Gly
Ile Gln Gly Asp
Leu Ala Asp Asn
Leu Ala Asn Asp
Leu Asp Ala Asn
Leu Asp Gly Gln
Leu Asp Asn Ala
Leu Asp Gln Gly
Leu Glu Gly Asn
Leu Glu Asn Gly
Leu Gly Asp Gln
Leu Gly Glu Asn
Leu Gly Asn Glu
Leu Gly Gln Asp
Leu Asn Ala Asp
Leu Asn Asp Ala
Leu Asn Glu Gly
Leu Asn Gly Glu
Leu Gln Asp Gly
Leu Gln Gly Asp
Met Ala Asn Pro
C17H29N5O6S (431.18384540000005)
Met Ala Pro Asn
C17H29N5O6S (431.18384540000005)
Met Gly Pro Gln
C17H29N5O6S (431.18384540000005)
Met Gly Gln Pro
C17H29N5O6S (431.18384540000005)
Met Asn Ala Pro
C17H29N5O6S (431.18384540000005)
Met Asn Pro Ala
C17H29N5O6S (431.18384540000005)
Met Pro Ala Asn
C17H29N5O6S (431.18384540000005)
Met Pro Gly Gln
C17H29N5O6S (431.18384540000005)
Met Pro Asn Ala
C17H29N5O6S (431.18384540000005)
Met Pro Gln Gly
C17H29N5O6S (431.18384540000005)
Met Gln Gly Pro
C17H29N5O6S (431.18384540000005)
Met Gln Pro Gly
C17H29N5O6S (431.18384540000005)
Asn Ala Asp Ile
Asn Ala Asp Leu
Asn Ala Glu Val
Asn Ala Ile Asp
Asn Ala Leu Asp
Asn Ala Met Pro
C17H29N5O6S (431.18384540000005)
Asn Ala Asn Asn
Asn Ala Pro Met
C17H29N5O6S (431.18384540000005)
Asn Ala Val Glu
Asn Cys Pro Val
C17H29N5O6S (431.18384540000005)
Asn Cys Val Pro
C17H29N5O6S (431.18384540000005)
Asn Asp Ala Ile
Asn Asp Ala Leu
Asn Asp Ile Ala
Asn Asp Leu Ala
Asn Asp Pro Ser
Asn Asp Ser Pro
Asn Glu Ala Val
Asn Glu Gly Ile
Asn Glu Gly Leu
Asn Glu Ile Gly
Asn Glu Leu Gly
Asn Glu Val Ala
Asn Gly Glu Ile
Asn Gly Glu Leu
Asn Gly Ile Glu
Asn Gly Leu Glu
Asn Gly Asn Gln
Asn Gly Gln Asn
Asn Ile Ala Asp
Asn Ile Asp Ala
Asn Ile Glu Gly
Asn Ile Gly Glu
Asn Leu Ala Asp
Asn Leu Asp Ala
Asn Leu Glu Gly
Asn Leu Gly Glu
Asn Met Ala Pro
C17H29N5O6S (431.18384540000005)
Asn Met Pro Ala
C17H29N5O6S (431.18384540000005)
Asn Asn Ala Asn
Asn Asn Gly Gln
Asn Asn Asn Ala
Asn Asn Gln Gly
Asn Pro Ala Met
C17H29N5O6S (431.18384540000005)
Asn Pro Cys Val
C17H29N5O6S (431.18384540000005)
Asn Pro Asp Ser
Asn Pro Met Ala
C17H29N5O6S (431.18384540000005)
Asn Pro Ser Asp
Asn Pro Thr Thr
Asn Pro Val Cys
C17H29N5O6S (431.18384540000005)
Asn Gln Gly Asn
Asn Gln Asn Gly
Asn Ser Asp Pro
Asn Ser Pro Asp
Asn Thr Pro Thr
Asn Thr Thr Pro
Asn Val Ala Glu
Asn Val Cys Pro
C17H29N5O6S (431.18384540000005)
Asn Val Glu Ala
Asn Val Pro Cys
C17H29N5O6S (431.18384540000005)
Pro Ala Met Asn
C17H29N5O6S (431.18384540000005)
Pro Ala Asn Met
C17H29N5O6S (431.18384540000005)
Pro Cys Gly Arg
C16H29N7O5S (431.19507840000006)
Pro Cys Asn Val
C17H29N5O6S (431.18384540000005)
Pro Cys Arg Gly
C16H29N7O5S (431.19507840000006)
Pro Cys Val Asn
C17H29N5O6S (431.18384540000005)
Pro Asp Asn Ser
Pro Asp Ser Asn
Pro Gly Cys Arg
C16H29N7O5S (431.19507840000006)
Pro Gly Met Gln
C17H29N5O6S (431.18384540000005)
Pro Gly Gln Met
C17H29N5O6S (431.18384540000005)
Pro Gly Arg Cys
C16H29N7O5S (431.19507840000006)
Pro Met Ala Asn
C17H29N5O6S (431.18384540000005)
Pro Met Gly Gln
C17H29N5O6S (431.18384540000005)
Pro Met Asn Ala
C17H29N5O6S (431.18384540000005)
Pro Met Gln Gly
C17H29N5O6S (431.18384540000005)
Pro Asn Ala Met
C17H29N5O6S (431.18384540000005)
Pro Asn Cys Val
C17H29N5O6S (431.18384540000005)
Pro Asn Asp Ser
Pro Asn Met Ala
C17H29N5O6S (431.18384540000005)
Pro Asn Thr Thr
Pro Asn Val Cys
C17H29N5O6S (431.18384540000005)
Pro Gln Gly Met
C17H29N5O6S (431.18384540000005)
Pro Gln Met Gly
C17H29N5O6S (431.18384540000005)
Pro Gln Ser Thr
Pro Gln Thr Ser
Pro Arg Cys Gly
C16H29N7O5S (431.19507840000006)
Pro Arg Gly Cys
C16H29N7O5S (431.19507840000006)
Pro Ser Gln Thr
Pro Ser Thr Gln
Pro Thr Asn Thr
Pro Thr Gln Ser
Pro Thr Ser Gln
Pro Thr Thr Asn
Pro Val Cys Asn
C17H29N5O6S (431.18384540000005)
Pro Val Asn Cys
C17H29N5O6S (431.18384540000005)
Gln Ala Asp Val
Gln Ala Val Asp
Gln Asp Ala Val
Gln Asp Gly Ile
Gln Asp Gly Leu
Gln Asp Ile Gly
Gln Asp Leu Gly
Gln Asp Val Ala
Gln Glu Gly Val
Gln Glu Val Gly
Gln Gly Asp Ile
Gln Gly Asp Leu
Gln Gly Glu Val
Gln Gly Ile Asp
Gln Gly Leu Asp
Gln Gly Met Pro
C17H29N5O6S (431.18384540000005)
Gln Gly Asn Asn
Gln Gly Pro Met
C17H29N5O6S (431.18384540000005)
Gln Gly Val Glu
Gln Ile Asp Gly
Gln Ile Gly Asp
Gln Leu Asp Gly
Gln Leu Gly Asp
Gln Met Gly Pro
C17H29N5O6S (431.18384540000005)
Gln Met Pro Gly
C17H29N5O6S (431.18384540000005)
Gln Asn Gly Asn
Gln Asn Asn Gly
Gln Pro Gly Met
C17H29N5O6S (431.18384540000005)
Gln Pro Met Gly
C17H29N5O6S (431.18384540000005)
Gln Pro Ser Thr
Gln Pro Thr Ser
Gln Ser Pro Thr
Gln Ser Thr Pro
Gln Thr Pro Ser
Gln Thr Ser Pro
Gln Val Ala Asp
Gln Val Asp Ala
Gln Val Glu Gly
Gln Val Gly Glu
Arg Cys Gly Pro
C16H29N7O5S (431.19507840000006)
Arg Cys Pro Gly
C16H29N7O5S (431.19507840000006)
Arg Gly Cys Pro
C16H29N7O5S (431.19507840000006)
Arg Gly Pro Cys
C16H29N7O5S (431.19507840000006)
Arg Pro Cys Gly
C16H29N7O5S (431.19507840000006)
Arg Pro Gly Cys
C16H29N7O5S (431.19507840000006)
Ser Pro Gln Thr
Ser Pro Thr Gln
Ser Gln Pro Thr
Ser Gln Thr Pro
Ser Thr Pro Gln
Ser Thr Gln Pro
Thr Asn Pro Thr
Thr Asn Thr Pro
Thr Pro Asn Thr
Thr Pro Gln Ser
Thr Pro Ser Gln
Thr Pro Thr Asn
Thr Gln Pro Ser
Thr Gln Ser Pro
Thr Ser Pro Gln
Thr Ser Gln Pro
Thr Thr Asn Pro
Thr Thr Pro Asn
Val Ala Asp Gln
Val Ala Glu Asn
Val Ala Asn Glu
Val Ala Gln Asp
Val Cys Asn Pro
C17H29N5O6S (431.18384540000005)
Val Cys Pro Asn
C17H29N5O6S (431.18384540000005)
Val Asp Ala Gln
Val Asp Gln Ala
Val Glu Ala Asn
Val Glu Gly Gln
Val Glu Asn Ala
Val Glu Gln Gly
Val Gly Glu Gln
Val Gly Gln Glu
Val Asn Ala Glu
Val Asn Cys Pro
C17H29N5O6S (431.18384540000005)
Val Asn Glu Ala
Val Asn Pro Cys
C17H29N5O6S (431.18384540000005)
Val Pro Cys Asn
C17H29N5O6S (431.18384540000005)
Val Pro Asn Cys
C17H29N5O6S (431.18384540000005)
Val Gln Ala Asp
Val Gln Asp Ala
Val Gln Glu Gly
Val Gln Gly Glu
Dinor PGE2 Taurine
C20H33NO7S (431.1977628000001)
Quinagolide hydrochloride
C20H34ClN3O3S (431.20092840000007)
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists Quinagolide hydrochloride (CV205-502 hydrochloride) is a selective and orally active dopamine D2 receptor agonist. Quinagolide hydrochloride is an inhibitor of prolactin. Quinagolide hydrochloride down-regulates AKT levels and its phosphorylation. Quinagolide hydrochloride shows antitumor effects, it can be used for the research of cancer[1][2]. Quinagolide hydrochloride (CV205-502 hydrochloride) is a selective and orally active dopamine D2 receptor agonist. Quinagolide hydrochloride is an inhibitor of prolactin. Quinagolide hydrochloride down-regulates AKT levels and its phosphorylation. Quinagolide hydrochloride shows antitumor effects, it can be used for the research of cancer[1][2].
L-Octahydroindole-2-carboxylic acid benzyl ester 4-methylbenzenesulfonate
C23H29NO5S (431.17663440000007)
Ethaverine hydrochloride
C24H30ClNO4 (431.18632500000007)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor C93038 - Cation Channel Blocker
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-threonine phenylmethyl ester
Succinimidyl (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylate
sodium,1-dodecoxy-4-(2-hydroxyethylamino)-1,4-dioxobutane-2-sulfonate
C18H34NNaO7S (431.19535740000003)
2-Methyl-3-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-5-(trifluoromethyl)quinazolin-4-one
Xanomeline tartrate
C18H29N3O7S (431.17261240000005)
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs Xanomeline (LY 246708) is the potent agonist of muscarinic M1/M4 receptor with antipsychotic-like activity. Xanomeline (LY 246708) increases neuronal excitability. Xanomeline (LY 246708) can be used for the research of schizophrenia[1][2][3].
Esreboxetine succinate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
1-benzyl-N-(2-morpholinoethyl)-4-oxo-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxamide
(2E,4E)-5-[(1R,7S,8S,9R)-7-acetyloxy-4-methoxycarbonyl-9-methyl-11-oxo-10-oxatricyclo[6.3.2.01,7]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoate
(5Z)-4-methoxy-3-methyl-5-[(1R,6S,8R,9R,10R,11S)-11-methyl-6-[(2S,4S)-4-methyl-5-oxooxolan-2-yl]-13,14-dioxa-5-azatetracyclo[6.5.1.01,10.05,9]tetradecan-12-ylidene]furan-2-one
3-Furanyl-[4-[2-(3-methoxyphenyl)-5,6-dimethyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
1-Methyl-6-[(4-methyl-1-piperidinyl)sulfonyl]-3-[oxo(1-piperidinyl)methyl]-4-quinolinone
C22H29N3O4S (431.1878674000001)
3-Furanyl-[4-[2-(4-methoxyphenyl)-5,6-dimethyl-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]methanone
1-methyl-N-(2-methylcyclohexyl)-4-oxo-6-(1-pyrrolidinylsulfonyl)-3-quinolinecarboxamide
C22H29N3O4S (431.1878674000001)
N-[4-(diethylsulfamoyl)phenyl]-4-(4-morpholinylmethyl)benzamide
C22H29N3O4S (431.1878674000001)
4-Tert-butylbenzoic acid [2-[(2-methoxy-3-dibenzofuranyl)amino]-2-oxoethyl] ester
(4-Methylphenyl)-[4-[4-nitro-3-(3-pyridinylmethylamino)phenyl]-1-piperazinyl]methanone
(E)-3-[2-(azepan-1-yl)-9-methyl-4-oxopyrido[1,2-a]pyrimidin-3-yl]-2-cyano-N-(furan-2-ylmethyl)prop-2-enamide
(3R)-2-acetyl-N-ethyl-3-(2-hydroxyethyl)-4-[3-(5-pyrimidinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3S)-2-acetyl-N-ethyl-3-(2-hydroxyethyl)-4-[3-(5-pyrimidinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
N-[(4-chlorophenyl)methyl]-2-[(3S,5Z,8S,12S)-8-methyl-2,9-dioxo-1,10-diazabicyclo[10.3.0]pentadec-5-en-3-yl]acetamide
C23H30ClN3O3 (431.1975580000001)
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-7-phenyl-1-(2-pyridinylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
1-[(3aS,4R,9bR)-8-(2-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(2-pyridinyl)ethanone
1-[(3aS,4R,9bR)-8-(3-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(3-pyridinyl)ethanone
1-[(3aR,4S,9bS)-8-(3-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(3-pyridinyl)ethanone
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-7-phenyl-1-(2-pyridinylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
1-[(3aR,4R,9bS)-8-(2-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(2-pyridinyl)ethanone
1-[(3aR,4R,9bS)-8-(3-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(3-pyridinyl)ethanone
1-[(3aS,4S,9bR)-8-(3-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(3-pyridinyl)ethanone
3beta-Chloro-N,N-bis(2-chloroethyl)-androst-5-en-17beta-amine
C23H36Cl3N (431.19131860000005)
NVP 231
NVP 231 is a potent, specific, and reversible ceramide kinase (CerK) inhibitor(IC50=12 nM) that competitively inhibits binding of ceramide to CerK[1]. NVP 231 induces cell apoptosis by increasing DNA fragmentation and caspase-3 and caspase-9 cleavage[2].
(2s,3r)-2-[(2e,4e,6e,8e,10e)-10-ethylidene-11-methoxy-2,6,8-trimethyl-11-oxoundeca-2,4,6,8-tetraenoyl]-3-(3-hydroxypropanoyl)oxirane-2-carboximidic acid
methyl (7e,9e)-11-[2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
(1's,2r,2's,3's,6'r)-3'-ethyl-1'-methoxy-4-methyl-11'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-5'-oxa-10'-azaspiro[furan-2,4'-tricyclo[8.3.0.0²,⁶]tridecan]-11'-ene-5,13'-dione
4-methoxy-3-methyl-5-[(1r,3e,4s,5r,6s,8s,9s)-4-methyl-9-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-2,14-dioxa-10-azatetracyclo[6.5.1.0¹,⁵.0⁶,¹⁰]tetradecan-3-ylidene]furan-2-one
methyl (2e,3e,5e,7e,9e)-11-[(1s,4s,5r)-2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
methyl 11-[3,4-dihydroxy-1-(2-hydroxyethyl)-6-oxa-2-azabicyclo[3.1.0]hex-2-en-4-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
(2z,6e)-7-[(5r,5ar,6s,8as)-3-{[hydroxy(methoxy)methylidene]amino}-6-methyl-4-oxo-5h,5ah,6h,7h,8h,8ah,9h-cyclopenta[g]thiochromen-5-yl]-3-methylhepta-2,6-dienoic acid
C23H29NO5S (431.17663440000007)
methyl (9e)-11-[2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
(1r,9r,12s,13s)-12-(acetyloxy)-3-hydroxy-4,11-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,10-tetraen-13-yl acetate
(2e,6e)-8-{2-[(1s)-1-carboxy-2-methylpropyl]-4,6-dihydroxy-1-oxo-3h-isoindol-5-yl}-2,6-dimethylocta-2,6-dienoic acid
5,12-dihydroxy-9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-6,9-diene-8,11-dione
methyl (2e,3e,5e,7e,9e)-11-[(1s,4s,5s)-3,4-dihydroxy-1-(2-hydroxyethyl)-6-oxa-2-azabicyclo[3.1.0]hex-2-en-4-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
(19s,21s,23r)-5,12-dihydroxy-9-methoxy-10,22-dimethyl-4,17-dioxa-2,14,22-triazaheptacyclo[11.10.0.0²,⁶.0³,²¹.0⁷,¹².0¹⁴,¹⁸.0¹⁹,²³]tricosa-6,9-diene-8,11-dione
methyl (2e,3e,5z,7e,9e)-11-[(1s,4s,5r)-2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-1,2-dihydroxy-3-(2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)pyridin-4-one
(2s,10s,12r)-13-hydroxy-10-(2-methylbut-3-en-2-yl)-21-oxo-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-3-yl acetate
3-[(1r,2s,4ar,8ar)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-1,4-dihydroxypyridin-2-one
13-hydroxy-10-(2-methylbut-3-en-2-yl)-21-oxo-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-3-yl acetate
4-methoxy-3-methyl-5-[(1r,3z,4s,5r,6s,8s,9s)-4-methyl-9-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-2,14-dioxa-10-azatetracyclo[6.5.1.0¹,⁵.0⁶,¹⁰]tetradecan-3-ylidene]furan-2-one
(1s,9s,12s,13s)-12-(acetyloxy)-3-hydroxy-4,11-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2,4,6,10-tetraen-13-yl acetate
methyl 2-(dimethylamino)-3-hydroxy-14-oxo-4,10-bis(prop-1-en-2-yl)-13,15,16-trioxatetracyclo[9.2.2.1⁵,⁸.0¹,¹²]hexadeca-5,7-diene-7-carboxylate
4-methoxy-3-methyl-5-[(12e)-11-methyl-6-(4-methyl-5-oxooxolan-2-yl)-13,14-dioxa-5-azatetracyclo[6.5.1.0¹,¹⁰.0⁵,⁹]tetradecan-12-ylidene]furan-2-one
8-[2-(1-carboxy-2-methylpropyl)-4,6-dihydroxy-1-oxo-3h-isoindol-5-yl]-2,6-dimethylocta-2,6-dienoic acid
methyl 11-[2,4-dihydroxy-4-(2-hydroxyethyl)-6-oxa-3-azabicyclo[3.1.0]hex-2-en-1-yl]-2-ethylidene-4,6,10-trimethyl-11-oxoundeca-3,5,7,9-tetraenoate
2-(10-ethylidene-11-methoxy-2,6,8-trimethyl-11-oxoundeca-2,4,6,8-tetraenoyl)-3-(3-hydroxypropanoyl)oxirane-2-carboximidic acid
5-{2,5-dihydroxy-7-oxabicyclo[4.1.0]heptan-2-yl}-1,4-dihydroxy-3-(2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl)pyridin-2-one
(2s,10r,12s)-3-acetyl-12,13-dihydroxy-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-21-one
2-[(1s)-1-carboxy-2-(1h-indol-3-yl)ethyl]-5-hydroxy-5,7,7-trimethyl-9-oxo-5ah,6h-cyclopenta[g]isoquinolin-2-ium
[C26H27N2O4]+ (431.19707220000004)
7-(3-{[hydroxy(methoxy)methylidene]amino}-6-methyl-4-oxo-5h,5ah,6h,7h,8h,8ah,9h-cyclopenta[g]thiochromen-5-yl)-3-methylhepta-2,6-dienoic acid
C23H29NO5S (431.17663440000007)